Trinity Biotech (TRIB) Gains from Sales and Divestitures (2021 - 2024)
Trinity Biotech (TRIB) posted Gains from Sales and Divestitures of $962000.0 for Q4 2024, up 231.72% sequentially from $290000.0 in Q4 2023, and up 231.72% YoY from $290000.0 in Q1 2024.
Trinity Biotech (TRIB) Gains from Sales and Divestitures (2021 - 2024) Analysis & Trends
Trinity Biotech has reported Gains from Sales and Divestitures for 4 years, with the latest figure at $962000.0 in Q4 2024.
- Quarterly Gains from Sales and Divestitures rose 231.72% year-over-year to $962000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $4.3 million (up 2.05% YoY) and the FY2024 annual result came in at $1.4 million, down 87.32% from the prior year.
- Gains from Sales and Divestitures improved to $962000.0 in Q4 2024 per TRIB's latest filing, from $290000.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $3.0 million in Q4 2022 and troughed at $519.0 in Q2 2022.
- A 4-year average of $861097.8 and a median of $583000.0 in 2021 frame the typical range for Gains from Sales and Divestitures.
- The widest YoY moves for Gains from Sales and Divestitures: up 246.12% in 2022, down 91.45% in 2022.
- Over 4 years, Gains from Sales and Divestitures stood at $876000.0 in 2021, then surged by 246.12% to $3.0 million in 2022, then slumped by 90.44% to $290000.0 in 2023, then soared by 231.72% to $962000.0 in 2024.
- According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $962000.0, $290000.0, and $3.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.50 Mn | 1.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 962,000.00 |
| Dec 31, 2024 | 962,000.00 |
| Dec 31, 2023 | 290,000.00 |
| Dec 31, 2023 | 290,000.00 |
| Dec 31, 2022 | 3.03 Mn |
| Dec 31, 2022 | 3.03 Mn |
| Jun 30, 2022 | 519.00 |
| Jun 30, 2022 | 519.00 |
| Dec 31, 2021 | 876,000.00 |
| Dec 31, 2021 | 876,000.00 |
| Jun 30, 2021 | 6,068.00 |
| Jun 30, 2021 | 6,068.00 |